NCT02622698

Brief Summary

Investigators performed a randomized controlled trial of 62 patients undergoing elective abdominal operations. The treatment group was provided a liquid protein supplement and instructed to take a dose three times daily for the first 20 postoperative days. Investigators followed patients for six months and compared wound healing and changes in weight and laboratory values.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2011

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2011

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2012

Completed
3.5 years until next milestone

First Submitted

Initial submission to the registry

December 1, 2015

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 4, 2015

Completed
Last Updated

December 4, 2015

Status Verified

December 1, 2015

Enrollment Period

10 months

First QC Date

December 1, 2015

Last Update Submit

December 2, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in weight

    Mean preoperative weight compared to mean postoperative weight at each follow-up appointment. Weight recorded in pounds, subsequent measurements at each postoperative point were normalized to the preoperative weight and reported as a relative percentage of the preoperative weight.

    Preoperative, and then postoperative at 1-2 weeks, 3 weeks, 1 month, 2 months, 3 months, 6 months

Secondary Outcomes (5)

  • Wound healing

    Preoperative, and then postoperative at 1-2 weeks, 3 weeks, 1 month, 2 months, 3 months, 6 months

  • Change in white blood cell count (1x10 3/ uL)

    Preoperative, and then postoperative at 1-2 weeks, 3 weeks, 1 month, 2 months, 3 months, 6 months

  • Change in total protein (g/ dL)

    Preoperative, and then postoperative at 1-2 weeks, 3 weeks, 1 month, 2 months, 3 months, 6 months

  • Change in albumin (g/ dL)

    Preoperative, and then postoperative at 1-2 weeks, 3 weeks, 1 month, 2 months, 3 months, 6 months

  • Change in prealbumin (mg/ dL)

    Preoperative, and then postoperative at 1-2 weeks, 3 weeks, 1 month, 2 months, 3 months, 6 months

Study Arms (2)

Control

PLACEBO COMPARATOR

The patients in the control group did not receive any supplementation, and were directed to follow the dietary guidelines of their surgeon.

Other: Placebo

Treatment

EXPERIMENTAL

Patients were instructed to consume one ounce (containing 16 grams of protein) of the supplement three times daily. No other modifications were made to the patient's diet. Patients were provided with a total of 60 doses, which would last 20 days if they consumed each dose as instructed.

Dietary Supplement: Prostat AWC

Interventions

Prostat AWCDIETARY_SUPPLEMENT

Prostat AWC- patients received protein supplementation after surgery

Treatment
PlaceboOTHER

Placebo- Patients did not take any protein supplementation after surgery

Also known as: No intervention
Control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients scheduled to undergo abdominal surgery \[cholecystectomy, ventral hernia repair, colectomy, non-bariatric gastric surgery, appendectomy, small bowel resection, lysis of adhesions, liver resection, splenectomy, proctectomy, stoma construction, pancreatic surgery, duodenal surgery, adrenal surgery, renal surgery, or cystectomy\]

You may not qualify if:

  • Age less than 18 years
  • Pregnant
  • Abdominal surgery within the past 6 months
  • Inability to attend follow-up appointments for at least 6 months
  • Liver failure (Child-Pugh Class B or C) or kidney failure (glomerular filtration rate (GFR) less than 30).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
FED
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Christina Riojas, General Surgeon

Study Record Dates

First Submitted

December 1, 2015

First Posted

December 4, 2015

Study Start

August 1, 2011

Primary Completion

June 1, 2012

Study Completion

June 1, 2012

Last Updated

December 4, 2015

Record last verified: 2015-12